First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up

This publication has 15 references indexed in Scilit:

• Intraperitoneal Chemotherapy for Ovarian Carcinoma: Results of Long-Term Follow-Up
  Journal of Clinical Oncology, 2002
• Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
  Journal of Clinical Oncology, 2001
• The platelet-sparing effect of paclitaxel is not related to changes in the pharmacokinetics of carboplatin
  Cancer Chemotherapy and Pharmacology, 2000
• Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
  New England Journal of Medicine, 1996
• A Phase II Trial of Intraperitoneal High-Dose Carboplatin and Etoposide with Granulocyte Macrophage-Colony Stimulating Factor Support in Patients with Ovarian Carcinoma
  American Journal of Clinical Oncology, 1995
• Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin
  British Journal of Cancer, 1994
• Phase II trial of intraperitoneal carboplatin in ovarian carcinoma patients with macroscopic residual disease at second-look laparotomy
  Annals of Oncology, 1994
• A Phase II Study of Intraperitoneal Carboplatin as Adjuvant Treatment in Early-Stage Ovarian Cancer Patients
  Gynecologic Oncology, 1994
• Evidence Supporting the Superiority of Intraperitoneal Cisplatin Compared to Intraperitoneal Carboplatin for Salvage Therapy of Small-Volume Residual Ovarian Cancer
  Gynecologic Oncology, 1993
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958